# NYSTATIN
> **ANDA214346** · Abbreviated New Drug Application (Generic) · Sponsor: SENORES PHARMS · Approved 2022-03-10
## Drug
- **FDA Application Number:** ANDA214346
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NYSTATIN
- **Generic name:** NYSTATIN
- **Active ingredients:** NYSTATIN
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SENORES PHARMS
- **Manufacturer:** Leading Pharma, LLC
- **First approval:** 2022-03-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214346)
---
*AI Analytics · CC0 1.0*